Shield Therapeutics (LON: STX) says the US FDA has accepted ACCRUFeR as a clinical supplement and assigned priority review to extend coverage to children with iron deficiency anaemia. Approval could be received in 2026. This follows positive results from a phase 3 paediatric clinical trial. The share price jumped 32.5% to 8.35p. Block Energy (LON: […]

The post AIM movers: Potential extended use for Shield Therapeutics’ ACCRUFeR iron deficiency treatment and ex-dividends appeared first on UK Investor Magazine.

Helium One Global (LON: HE1) says the Itumbula West-1 has reached its total depth of 961 metres and elevated helium shows have been consistently measured. The helium shows increased in frequency and concentration in fault zones. Formulation evaluation will be done and then drill stem testing across zones of interest. The share price jumped 58.4% […]

The post AIM movers: Newmark Security revenues dip and ex-dividends appeared first on UK Investor Magazine.

Managed IT services provider CloudCoCo (LON: CLCO) trebled revenues to £24m in the year to September 2022, while EBITDA improved from £745,000 to around £1m. There were four acquisitions in late 2021 so they contributed to the growth. Investment is sales is starting to pay off and there should be further growth in revenues and […]

The post AIM movers: CloudCoCo growth and ex-dividends appeared first on UK Investor Magazine.